Potent monocarboxylate transporter 1 inhibitors (MCT1) have been developed based on α-cyano-4-hydroxycinnamic acid template. Structure-activity relationship studies demonstrate that the introduction of p-N, N-dialkyl/diaryl, and o-methoxy groups into cyanocinnamic acid has maximal MCT1 inhibitory activity. Systemic toxicity studies in healthy ICR mice with few potent MCT1 inhibitors indicate normal body weight gains in treated animals. In vivo tumor growth inhibition studies in colorectal adenocarcinoma (WiDr cell line) in nude mice xenograft models establish that compound 27 exhibits single agent activity in inhibiting the tumor growth.
|Original language||English (US)|
|Number of pages||4|
|Journal||ACS Medicinal Chemistry Letters|
|State||Published - May 14 2015|
Bibliographical notePublisher Copyright:
© 2015 American Chemical Society.
- Warburg effect
- colorectal adenocarcinoma
- monocarboxylate transporter 1
- reverse Warburg effect
- α-cyano-4-hydroxycinnamic acid